Lantheus Holdings (LNTH) Long-Term Deferred Tax (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Long-Term Deferred Tax came in at $89.1 million in Q1 2026, down 47.23% year-on-year from $168.9 million in Q1 2025, and down 18.38% on a QoQ basis from $109.2 million in Q4 2025.
Lantheus Holdings (LNTH) Long-Term Deferred Tax (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Long-Term Deferred Tax data on file, last reported at $89.1 million in Q1 2026.
- On a quarterly basis, Long-Term Deferred Tax fell 47.23% year-over-year to $89.1 million in Q1 2026; TTM through Mar 2026 was $89.1 million, a 47.23% decrease from a year earlier, with the FY2025 full-year figure at $109.2 million, down 35.85% from the prior year.
- Long-Term Deferred Tax for Q1 2026 stood at $89.1 million, down from $109.2 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for LNTH reached as high as $170.2 million in Q4 2024 and fell as low as $46.8 million in Q3 2022.
- Historically, Long-Term Deferred Tax has averaged $120.5 million across 5 years, with a median of $134.2 million in 2023.
- Across the five-year window, Long-Term Deferred Tax soared 225.15% in 2023 and plunged 47.23% in 2026, its largest moves.
- Year by year, Long-Term Deferred Tax stood at $110.6 million in 2022, then surged by 35.75% to $150.2 million in 2023, then climbed by 13.34% to $170.2 million in 2024, then tumbled by 35.85% to $109.2 million in 2025, then dropped by 18.38% to $89.1 million in 2026.
- Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $89.1 million in Q1 2026, $109.2 million in Q4 2025, and $107.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.12 Mn |
| Dec 31, 2025 | 109.20 Mn |
| Sep 30, 2025 | 107.45 Mn |
| Jun 30, 2025 | 138.26 Mn |
| Mar 31, 2025 | 168.89 Mn |
| Dec 31, 2024 | 170.23 Mn |
| Sep 30, 2024 | 144.64 Mn |
| Jun 30, 2024 | 151.19 Mn |
| Mar 31, 2024 | 138.90 Mn |
| Dec 31, 2023 | 150.20 Mn |
| Sep 30, 2023 | 152.19 Mn |
| Jun 30, 2023 | 134.20 Mn |
| Mar 31, 2023 | 133.87 Mn |
| Dec 31, 2022 | 110.65 Mn |
| Sep 30, 2022 | 46.81 Mn |
| Jun 30, 2022 | 55.16 Mn |
| Mar 31, 2022 | 47.87 Mn |
| Dec 31, 2021 | 62.76 Mn |
| Sep 30, 2021 | 66.49 Mn |
| Jun 30, 2021 | 64.78 Mn |